These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 11382533)
1. Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment. Chuang JI; Chen ST; Chang YH; Jen LS J Chem Neuroanat; 2001 May; 21(3):215-23. PubMed ID: 11382533 [TBL] [Abstract][Full Text] [Related]
2. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease. Carriere CH; Kang NH; Niles LP Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407 [TBL] [Abstract][Full Text] [Related]
3. The antioxidant melatonin reduces cortical neuronal death after intrastriatal injection of kainate in the rat. Chen ST; Chuang JI Exp Brain Res; 1999 Jan; 124(2):241-7. PubMed ID: 9928847 [TBL] [Abstract][Full Text] [Related]
4. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats. Ananth C; Gopalakrishnakone P; Kaur C Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978 [TBL] [Abstract][Full Text] [Related]
5. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia. Ryu JK; Shin WH; Kim J; Joe EH; Lee YB; Cho KG; Oh YJ; Kim SU; Jin BK Glia; 2002 Apr; 38(1):15-23. PubMed ID: 11921200 [TBL] [Abstract][Full Text] [Related]
6. Acute administration of haloperidol induces apoptosis of neurones in the striatum and substantia nigra in the rat. Mitchell IJ; Cooper AC; Griffiths MR; Cooper AJ Neuroscience; 2002; 109(1):89-99. PubMed ID: 11784702 [TBL] [Abstract][Full Text] [Related]
7. Selective microglial activation in the rat rotenone model of Parkinson's disease. Sherer TB; Betarbet R; Kim JH; Greenamyre JT Neurosci Lett; 2003 May; 341(2):87-90. PubMed ID: 12686372 [TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway. Chen ST; Chuang JI; Hong MH; Li EI J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Tomás-Camardiel M; Herrera AJ; Venero JL; Cruz Sánchez-Hidalgo M; Cano J; Machado A Brain Res Mol Brain Res; 2002 Jun; 103(1-2):116-29. PubMed ID: 12106697 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of Bcl-2 and APP immunoreactivity after intrastriatal injection of MPP+ in the rat. Chuang JI; Chen ST Neurochem Int; 2002 Feb; 40(2):169-79. PubMed ID: 11738483 [TBL] [Abstract][Full Text] [Related]
12. Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats. Huh Y; Jung JW; Park C; Ryu JR; Shin CY; Kim WK; Ryu JH Neurosci Lett; 2003 Sep; 349(1):63-7. PubMed ID: 12946587 [TBL] [Abstract][Full Text] [Related]
13. Astroglial and microglial activation in the wistar rat ventral tegmental area after a single striatal injection of 6-hydroxydopamine. Rodrigues RW; Gomide VC; Chadi G Int J Neurosci; 2004 Feb; 114(2):197-216. PubMed ID: 14702208 [TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Cicchetti F; Brownell AL; Williams K; Chen YI; Livni E; Isacson O Eur J Neurosci; 2002 Mar; 15(6):991-8. PubMed ID: 11918659 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Matsuura K; Makino H; Ogawa N Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064 [TBL] [Abstract][Full Text] [Related]
16. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system. Kim YS; Joo WS; Jin BK; Cho YH; Baik HH; Park CW Neuroreport; 1998 Jul; 9(10):2387-90. PubMed ID: 9694233 [TBL] [Abstract][Full Text] [Related]
17. Robust regeneration of CNS axons through a track depleted of CNS glia. Moon LD; Brecknell JE; Franklin RJ; Dunnett SB; Fawcett JW Exp Neurol; 2000 Jan; 161(1):49-66. PubMed ID: 10683273 [TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. Pérez-Navarro E; Gavaldà N; Gratacòs E; Alberch J J Neurochem; 2005 Feb; 92(3):678-91. PubMed ID: 15659237 [TBL] [Abstract][Full Text] [Related]
19. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Aksenov MY; Hasselrot U; Wu G; Nath A; Anderson C; Mactutus CF; Booze RM Brain Res; 2003 Oct; 987(1):1-9. PubMed ID: 14499939 [TBL] [Abstract][Full Text] [Related]
20. Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain. Mennicken F; Chabot JG; Quirion R Glia; 2002 Feb; 37(2):124-38. PubMed ID: 11754211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]